H. Sovalat
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Hematology 15
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 2
- Genetics 8
- Mesenchymal stem cell research 6
- Co-authors
- Philippe Hénon (12 shared papers)E. Wunder (11 shared papers)Stefan Serke (3 shared papers)Valérie Rimelen (3 shared papers)F Silvestri (2 shared papers)G. Fritsch (2 shared papers)Mario Ojeda‐Uribe (4 shared papers)Carine Schmitt (1 shared paper)
In The Last Decade
H. Sovalat
21 papers receiving 348 citations
Peers
Comparison fields: 5 of 54
- Hematology 173
- Genetics 103
- Immunology 68
- Immunology and Allergy 16
- Oncology 66
Countries citing papers authored by H. Sovalat
This map shows the geographic impact of H. Sovalat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sovalat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sovalat more than expected).
Fields of papers citing papers by H. Sovalat
This network shows the impact of papers produced by H. Sovalat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sovalat. The network helps show where H. Sovalat may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Sovalat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 69 | |
| 2 | 2011 | 60 | |
| 3 | 1992 | 54 | |
| 4 | 2009 | 38 | |
| 5 | 2015 | 22 | |
| 6 | Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment. | 2001 | 18 |
| 7 | 2003 | 16 | |
| 8 | 1993 | 16 | |
| 9 | 1998 | 16 | |
| 10 | 2004 | 14 | |
| 11 | 1993 | 13 | |
| 12 | 2009 | 12 | |
| 13 | 1992 | 11 | |
| 14 | Comparative analysis of class I, II and III epitope-detecting CD34 monoclonal antibodies by quantitative flow cytometry. | 1998 | 9 |
| 15 | Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia. | 1994 | 3 |
| 16 | 1992 | 3 | |
| 17 | 2013 | 2 | |
| 18 | 1993 | 2 | |
| 19 | 2000 | 1 | |
| 20 | Impeded normal hematopoiesis in bone marrow of patients with multiple myeloma. | 1995 | 1 |
About H. Sovalat
H. Sovalat is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 381 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (7 papers), Mesenchymal stem cell research (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Immunotherapy and Immune Responses (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Neonatal Respiratory Health Research (2 papers). The work is most often cited by research in Hematology (173 citations), Genetics (103 citations), Immunology (68 citations), Immunology and Allergy (16 citations) and Oncology (66 citations). H. Sovalat has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Philippe Hénon, E. Wunder, Stefan Serke, Valérie Rimelen, F Silvestri, G. Fritsch, Mario Ojeda‐Uribe, Carine Schmitt, Georges Herbein and Christine Schweitzer. Their work appears in journals such as Stem Cells, Cytotherapy, Experimental Hematology, Blood and Stem Cells International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.